A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4+ t cells-Reference-Cited by-同舟云学术

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4+ t cells

Published:2003-03 Issue:3 Volume:106 Page:188-196
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

de Boer Alberdina W,Markowitz Norman,Lane H.Clifford,Saravolatz Louis D,Koletar Susan L,Donabedian Haig,Yoshizawa Carl,Duliege Anne-Marie,Fyfe Gwendolyn,Mitsuyasu Ronald T

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. The impact of highly active antiretroviral therapy on HIV-specific immune function;Saag;AIDS,2001

2. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection—a preliminary study;Kovacs;N. Engl. J. Med.,1995

3. Controlled trial of interleukin-2-infusions in patients infected with the human immunodeficiency virus;Kovacs;N. Engl. J. Med.,1996

4. Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons;Davey;J. Infect. Dis.,1997

5. A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection;Davey;J. Infect. Dis.,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Perfusion and Primary Hepatocytes for Studying Drug Metabolism and Metabolite Excretion;Oral Bioavailability and Drug Delivery;2023-10-10

2. New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144;Scientific Reports;2020-02-19

3. Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults;Cochrane Database of Systematic Reviews;2017-05-25

4. Liver Perfusion and Primary Hepatocytes for Studying Drug Metabolism and Metabolite Excretion;Oral Bioavailability;2011-07-05

5. Immunotherapeutic restoration in HIV-infected individuals;Immunotherapy;2011-02